EV-Pure

N/A

Report date: 2025/02/28 10:17:50

Base Information

Drug NameEV-Pure
Drug Alias NameAn acellular product that contains over 15 billion pure exosomes per lee（Vitti Labs）EV-PURE
ClassificationBiologics > Exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Primary Ovarian InsufficiencyOvarian Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVitti Labs LLC
China Registration ClassN/A

Develop Information

Active CompaniesVitti Labs LLC
Inactive CompaniesN/A
Active IndicationsInfertility
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Primary Ovarian InsufficiencyOvarian Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A